December 2006 Archive

Dec 29, 2006

Taking one of the popular heartburn drugs such as Nexium, Prevacid or Prilosec? If you’re over the age of 50 take heed—taking the drugs for more than a year can raise your chances of a broken hip, a British study found.

Dec 20, 2006

The Food and Drug Administration (FDA) proposed stronger warning labels for over-the-counter drugs that are more dangerous than previously indicated. Labels will include warnings about liver failure resulting from overuse of acetaminophens and gastrointestinal bleeding from overuse of nonsteroidal anti-inflammatories (NSAIDS).

Dec 18, 2006

According to internal Eli Lilly documents and e-mails, sales reps were encouraged to play down Zyprexa’s risks for obesity and diabetes. They were also encouraged to promote the drug to treat dementia, even though it was only approved to treat schizophrenia and bipolar disorder.

Dec 13, 2006

The Food and Drug Administration (FDA) will decide if antidepressant labels should include a warning for patients that the drugs can increase suicidal thoughts and behavior in patients up to age 24. Currently, antidepressants carry a “black box” warning label for children and adolescents.

Dec 08, 2006

The younger the antidepressant user, the more likely they are to have suicidal thoughts. That’s the conclusion the Food and Drug Administration (FDA) had after they researched 372 clinical studies involving 11 antidepressants to see if increased suicidal thoughts and behavior in children continued through to adulthood. The study involved over 100,000 patients and dated back to 1985.

Dec 07, 2006

Despite two manufacturers of drug-coated stents claiming the benefits of their devices outweigh the risks, the Food and Drug Administration (FDA) believes they pose a risk of death and raise other safety concerns. Clotting risks and patient precautions associated with drug-coated stents are among the topics planned for discussion at the FDA's meeting with Boston Scientific, Johnson & Johnson, and an outside panel of medical experts.

Dec 04, 2006

Pfizer officially announced that it is halting development of what was to be one of their most promising drugs, torcetrapib. The drug was the first in a new class of drugs known as CETP inhibitors, which would have helped increase the amount of “good” cholesterol, or HDL, reducing heart disease.

Dec 01, 2006

If you are pregnant or plan to become pregnant, you may want to stay clear of the antidepressant drug Paxil, according to the American College of Obstetricians and Gynecologists. This warning comes a year after the Food and Drug Administration (FDA) and GlaxoSmithKline reclassified the antidepressant because studies of pregnant women showed a risk to the fetus.